ENDRA Life Sciences Investor Relations Material
Latest events
Q2 2024
ENDRA Life Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ENDRA Life Sciences Inc
Access all reports
ENDRA Life Sciences Inc. is a medical technology company focused on developing advanced ultrasound technologies for clinical use. Its main product, the Thermo-Acoustic Enhanced Ultrasound (TAEUS) platform, is designed to provide imaging capabilities similar to MRI, but at a fraction of the cost and at the point of care. ENDRA’s technology is primarily aimed at improving the diagnosis and monitoring of liver disease, particularly non-alcoholic fatty liver disease (NAFLD), with potential applications in other conditions. The company is headquartered in Ann Arbor, Michigan, USA, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NDRA
Country
🇺🇸 United States